ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Establishment of a prognostic model based on m6A regulatory factors and stemness of hepatocellular carcinoma using RNA-seq data and scRNA-seq data

Liang, Yan; Chen, Sen; Xie, Jinghe; Yan, Guanrong; Guo, Tingting; Li, Tianyang; Liu, Shoupei; Zeng, Weiping; Zhang, Shuai; Ma, Keqiang; Chen, Honglin; Ou, Yimeng*; Wang, Bailin*; Gu, Weili*; Duan, Yuyou*广东药学院; 河北医科大学; 1
Journal of Cancer Research and Clinical Oncology2023-11DOI: 10.1007/s00432-023-05045-x
1被引11阅读
引用收藏
分享

摘要

BackgroundHepatocellular carcinoma (HCC) with high incidence and mortality is one of the most common malignant cancers worldwide. Increasing evidence has reported that N6-methyladenosine (m(6)A) modification has been considered as a major contribution to the occurrence and development of tumors.MethodIn our study, we comprehensively analyzed the connection between m(6)A regulatory factors and cancer stem cells (CSCs) of HCC to establish a clinical tool for predicting its outcome. First, we concluded that the expression level of m(6)A regulatory factors was related with the stemness of hepatocellular carcinoma. Subsequently, we gained a ten hub regulatory factors that were associated with prognosis of hepatocellular carcinoma by overall survival (OS) analysis using ICGC and TCGA datasets, and these regulatory factors included YTHDF1, IGF2BP1, METTL3, IGF2BP3, HNRNPA2B1, IGF2BP2, RBM15B, HNRNPC, RBMX, and LRPPR. Next, we found that these ten hub m(6)A regulatory factors were highly expressed in CSCs, and CSCs related pathways were also enriched by the gene set variation analysis (GSVA). Then, correlation, consensus clustering and PCA analysis were performed to reveal potential therapeutic benefits of HCC. Moreover, univariate Cox regression (UNICOX), LASSON and multivariate Cox regression (MULTICOX) analyses were adopted to establish HCC prognosis prediction signature.ResultsFour regulatory factors RBM15B, LRPPRC, IGF2BP1, and IGF2BP3 were picked as valuable prognostic indicators.ConclusionIn summary, these ten hub regulatory factors would be useful therapeutic targets for HCC treatment, and RBM15B/LRPPRC/IGF2BP1/IGF2BP3 prognostic indicators can be used to guide therapy for HCC patients.

学科与关键词

关键词
HCCm(6)A modificationCSCsStemnessPrognostic model
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Journal of Cancer Research and Clinical Oncology
发表日期
2023-11
卷期
第 149 卷, 第 14 期
页码
12881-12896
DOI
10.1007/s00432-023-05045-x
语言
ENGLISH
成果收录
SCIE

作者

  • L

    Liang, Yan (第一作者)

  • C

    Chen, Sen

    2 · inst med

查看全部 15 位作者收起作者
  • X

    Xie, Jinghe

  • Y

    Yan, Guanrong

  • G

    Guo, Tingting

    2 · inst med

  • L

    Li, Tianyang

    1

  • L

    Liu, Shoupei

    2 · inst med

  • Z

    Zeng, Weiping

  • Z

    Zhang, Shuai

    1

  • M

    Ma, Keqiang

  • C

    Chen, Honglin

  • O

    Ou, Yimeng (通讯)

    1 · guangdong pharmaceut univ

  • W

    Wang, Bailin (通讯)

  • G

    Gu, Weili (通讯)

    1

  • D

    Duan, Yuyou (通讯)

    2 · inst med · 1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417